Provista Announces New Chief Financial Officer and Expands Commercial Team Expertise
New York, NY – April 6, 2016 – Provista Diagnostics, Inc., a company developing and commercializing molecular diagnostic, prognostic and monitoring tests for cancers affecting women, has promoted Uriel Kusiatin, MBA to Chief Financial Officer and Kelly Gordon, PhD, MB (ASCP CM), to Vice President of Research and Development.
Read More
Age more than just a number in breast cancer
NEW YORK—Privately held molecular diagnostics company Provista Diagnostics, Inc.
Read More2015 San Antonio Breast Cancer Conference
2015 San Antonio Breast Cancer Conference; Dates: Tuesday, December 8 – Saturday, December 12
Read More
